Barry Jacobson to Treatment Outcome
This is a "connection" page, showing publications Barry Jacobson has written about Treatment Outcome.
Connection Strength
0,209
-
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost. 2010 Dec; 104(6):1228-34.
Score: 0,073
-
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF. Open Heart. 2024 Jul 01; 11(2).
Score: 0,047
-
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. Lancet Haematol. 2022 Aug; 9(8):e594-e604.
Score: 0,041
-
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. PLoS One. 2016; 11(10):e0164076.
Score: 0,028
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 04 05; 366(14):1287-97.
Score: 0,020